Background: The cardiovascular risk profile of the population in the Czech Republic is unfavourable, the mortality of the population from cardiovascular diseases is among the highest in the world. The objective of the present work was to compare the prevalence of the most serious risk factors in 1988 and 1992 and to find out whether the change of the political and economic system in 1989 had an impact on the risk profile of the population. Within the framework of the international WHO project MONICA independent 1% random population samples, age bracket 25-64 years, were examined in six districts of the Czech Republic.
Methods And Results: In 1988 1,357 men (response rate 85.5%) and 1,412 women (88.4%) were examined; in 1992 1,139 men (71.2%) and 1,214 women (75.0%) attended the examination. The prevalence of smokers (regular consumption of more than 1 cigarette per day) did not differ significantly in men: 41.8% in 1988, 40.3% in 1992 nor in women: 25.3%-24.1%. Also the prevalence of elevated blood pressure levels (BPs > 21.3 and/or BPd > 12.7 kPa) did not reveal a significant difference neither in men: 19.1%-20.4% nor in women 14.0%-15.0%. The prevalence of hypercholesterolaemia (total cholesterol > 6.5 mmol/l) was in 1992 significantly lower than in 1988--in men by 9% (39.6%-30.6%, p < 0.001) and in women by 6.3% (36.3%-30.0%, p < 0.001). Also in the prevalence of obesity (BMI men > 30, women > 29) a significant drop was recorded in men by 5.2% (23.8%-18.6%, p < 0.01) in women by 5.1% (33.3%-28.2%, p < 0.01).
Conclusions: The probable reason for this partial improvement of the risk profile in 1992, as compared with data in 1988, are dietary changes which may be the result of the introduced market economy and global transformation of society after the political change in 1989.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol.
Int J Rheum Dis
January 2025
Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan.
Aim: Uncontrolled chronic inflammatory diseases (CIDs) before, during, and after pregnancy, as well as some CID medications, can increase the risk of impaired fertility in addition to adverse maternal/pregnancy outcomes in women of childbearing age. We report pregnancy outcomes from prospectively reported pregnancies in Japanese women treated with certolizumab pegol (CZP).
Methods: Data from July 2001 to November 2020 on CZP-exposed pregnancies from the CZP Pharmacovigilance safety database were reviewed.
Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders.
Med Gas Res
January 2025
McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Xenon gas is considered to be a safe anesthetic and imaging agent. Research on its other potentially beneficial effects suggests that xenon may have broad efficacy for treating health disorders. A number of reviews on xenon applications have been published, but none have focused on substance use disorders.
View Article and Find Full Text PDFEnhancing accessibility to the dementia risk profile (DRP) and knowledge of dementia risk reduction (KoDeRR) measuring tools to diverse communities through translation and adaptation in the Nepali language.
Dementia (London)
January 2025
Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Australia.
Dementia is one of the fastest emerging global public health concerns today, as the World Health Organisation has predicted that the number of cases will triple from 55 million in 2023 to 152 million by 2050. Current evidence indicates that approximately 45% of dementia cases can be prevented or delayed by acting on potentially modifiable risk factors. However, public knowledge regarding this remains unknown in numerous poorly resourced countries, including Nepal, where the prevalence of dementia continues to increase.
View Article and Find Full Text PDFA Mitochondria-Related Signature in Diffuse Large B-Cell Lymphoma: Prognosis, Immune and Therapeutic Features.
Cancer Med
January 2025
Department of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.
Background: Distinctive heterogeneity characterizes diffuse large B-cell lymphoma (DLBCL), one of the most frequent types of non-Hodgkin's lymphoma. Mitochondria have been demonstrated to be closely involved in tumorigenesis and progression, particularly in DLBCL.
Objective: The purposes of this study were to identify the prognostic mitochondria-related genes (MRGs) in DLBCL, and to develop a risk model based on MRGs and machine learning algorithms.
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinoma.
Histopathology
January 2025
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Aims: Classification and risk stratification of endometrial carcinoma (EC) has transitioned from histopathological features to molecular classification, e.g. the ProMisE classifier, identifying four prognostic subtypes: POLE mutant (POLEmut) with almost no recurrence or disease-specific death events, mismatch repair deficient (MMRd) and no specific molecular profile (NSMP), with intermediate outcome and p53 abnormal (p53abn) with poor outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!